Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$8.10bn129.26n/a
au flag iconMSBMesoblastAU$1.88bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$943.18mn/an/a
au flag iconPYCPYC TherapeuticsAU$746.57mn/an/a
au flag iconIMMImmutepAU$356.62mn/an/a
au flag iconDXBDimerixAU$323.56mn/an/a
au flag iconCGSCogstateAU$285.39m25.69n/a
au flag iconRACRace OncologyAU$198.90mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$181.08mn/an/a
au flag iconATXAmplia TherapeuticsAU$114.45mn/an/a
au flag iconALAArovella TherapeuticsAU$104.88mn/an/a
au flag iconIMUDAImugeneAU$92.99mn/an/a
au flag iconAGNArgenica TherapeuticsAU$88.38mn/an/a
au flag iconBXNBioxyneAU$81.97m30.3n/a
au flag iconSNTSyntaraAU$78.96mn/an/a
au flag iconACWActinogen MedicalAU$78.32mn/an/a
nz flag iconPEBPacific EdgeNZ$78.76mn/an/a
au flag iconGD8GO-DX (Aust)AU$61.94mn/an/a
au flag iconLTPLtr PharmaAU$58.82mn/an/a
au flag iconPIQProteomics International LaboratoriesAU$55.68mn/an/a